Key result
Dexmedetomidine was suggested to reduce mortality, major complications, and length of stay in cardiac surgery patients, though inconsistent results highlight the need for high-quality trials.
Why the study?
Dexmedetomidine is increasingly used in cardiac surgery patients, but studies and clinical trials have shown inconsistent results regarding its clinical effects.
Does dexmedetomidine reduce mortality, major complications, and length of stay in patients who underwent cardiac surgery?
Population
Patients who underwent cardiac surgery
Comparison
Dexmedetomidine vs not specified
Design
Review of retrospective studies and clinical trials
Authors
Loading...
Should not yet change practice in cardiac surgery; leaves open a mortality benefit pending randomized confirmation.
Does dexmedetomidine reduce mortality, major complications, and length of stay in patients who underwent cardiac surgery?
Dexmedetomidine may improve clinical outcomes including mortality and length of stay in cardiac surgery patients, though high-quality randomized trials are needed to confirm these findings.
Xiao et al. (2023) conducted a review in Cardiac surgery. Dexmedetomidine was evaluated on Mortality, major complications, and intensive care unit and hospital length of stay. Dexmedetomidine was suggested to reduce mortality, major complications, and length of stay in cardiac surgery patients, though inconsistent results highlight the need for high-quality trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: